And FOCUS 2024 announcement

Metabolic imaging in GU cancers Future association between local and vectorized treatment in PCa Internal vectorized radiotherapy sequences in the management of metastatic prostate cancer

Micro ultrasound versus MRI fusion biopsies Active surveillance without biopsy: ready for prime time? YES versus NO

New challenges and opportunities in the management of genito-urinary cancers Treatment sequencing in the management of metastatic urothelial cancers Management of high-risk biochemical relapse after... Read More

Specific clinical settings in the era of new treatments Management of metastatic non-clear cell kidney cancer Delayed nephrectomies: potential indications and outcomes

Which second generation hormonal treatment to choose in mHSPC? A personalized approach Metachronous low volume mHSPC: intermitent, doublet or triplet therapy? Strategy to delay systemic... Read More

Implementation of biomarkers in daily practice How to use biomarkers from localized to castration resistant prostate cancer? How to use biomarkers from NMIBC to metastatic... Read More